Suppr超能文献

双眼同一天接受抗血管内皮生长因子玻璃体内注射后的眼内炎发生率。

Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

机构信息

The Retina Service, Wills Eye Hospital, Philadelphia, Pennsylvania, USA.

The Retina Service, Wills Eye Hospital, Philadelphia, Pennsylvania, USA.

出版信息

Am J Ophthalmol. 2018 Oct;194:1-6. doi: 10.1016/j.ajo.2018.06.022. Epub 2018 Jul 6.

Abstract

PURPOSE

To evaluate practice patterns for bilateral same-day intravitreal anti-vascular endothelial growth factor (VEGF) injections and determine the rate of unilateral and bilateral postinjection endophthalmitis after bilateral same-day intravitreal anti-VEGF injections.

DESIGN

Retrospective cohort study.

METHODS

The records of a large academic private practice were electronically queried for all office visits, during which bilateral intravitreal anti-VEGF injections were performed between April 1, 2012 and August 21, 2017 for patients with a diagnosis of neovascular age-related macular degeneration, diabetic macular edema, or retinal vein occlusion. Demographic information and indication for injection were recorded for each patient and office visit. Charts of patients with endophthalmitis were reviewed, and information was collected on presentation examination, culture data, and visual outcomes.

RESULTS

During the study period, 101 932 bilateral same-day intravitreal anti-VEGF injections were performed over 50 966 office visits for 5890 patients. The mean (standard deviation) age of patients in this cohort was 74.2 (14.1) years and 60.6% of patients were female. The 2 most common indications for injection were neovascular age-related macular degeneration (54.3% of patients) and diabetic macular edema (35.4% of patients). Twenty-eight cases of endophthalmitis (0.027% of total injections) occurred during the study period. There were no cases of bilateral endophthalmitis, and no patients had more than 1 occurrence of endophthalmitis.

CONCLUSIONS

In this large cohort of patients undergoing bilateral same-day intravitreal anti-VEGF injections, there were no cases of bilateral endophthalmitis. Additionally, the overall rate of unilateral endophthalmitis was low and comparable to prior studies of unilateral injections. These results support the safety of bilateral same-day intravitreal anti-VEGF treatment.

摘要

目的

评估双眼同日玻璃体内抗血管内皮生长因子(VEGF)注射的治疗模式,并确定双眼同日玻璃体内抗 VEGF 注射后单侧和双侧眼内炎的发生率。

设计

回顾性队列研究。

方法

电子检索 2012 年 4 月 1 日至 2017 年 8 月 21 日期间一家大型学术私人执业机构的所有就诊记录,在此期间对患有新生血管性年龄相关性黄斑变性、糖尿病性黄斑水肿或视网膜静脉阻塞的患者进行了双眼同日玻璃体内抗 VEGF 注射。记录每位患者和每次就诊的人口统计学信息和注射指征。对眼内炎患者的病历进行了回顾,并收集了就诊时的检查、培养数据和视力结果。

结果

在研究期间,对 5890 名患者的 101932 例双眼同日玻璃体内抗 VEGF 注射进行了 50966 次就诊。该队列患者的平均(标准差)年龄为 74.2(14.1)岁,60.6%为女性。注射的 2 个最常见指征是新生血管性年龄相关性黄斑变性(54.3%的患者)和糖尿病性黄斑水肿(35.4%的患者)。研究期间共发生 28 例眼内炎(占总注射量的 0.027%)。无双侧眼内炎病例,也无患者发生 1 次以上眼内炎。

结论

在这项对接受双眼同日玻璃体内抗 VEGF 注射的大量患者进行的研究中,没有发生双侧眼内炎的病例。此外,单侧眼内炎的总体发生率较低,与单侧注射的既往研究结果相当。这些结果支持双眼同日玻璃体内抗 VEGF 治疗的安全性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验